Aptorum Stock Price

0.03 (3.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 151,066
Bid Price 0.87
Ask Price 1.06
News -
Day High 1.06


52 Week Range


Day Low 0.9201
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aptorum Group Ltd APM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03 3.0% 1.03 19:07:21
Open Price Low Price High Price Close Price Prev Close
0.98 0.9201 1.06 1.03 1.00
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
235 151,066 $ 1.02 $ 154,492 - 0.8553 - 3.54
Last Trade Time Type Quantity Stock Price Currency
17:02:18 6 $ 1.07 USD


Draw Mode:

Aptorum Group Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 36.77M 35.70M 8.13M $ 1.54M $ - -0.71 -1.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Aptorum News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical APM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.991.080.85530.978478570,4030.044.04%
1 Month1.371.530.85531.0774,630-0.34-24.82%
3 Months2.002.000.85531.40112,164-0.97-48.5%
6 Months2.222.420.85531.781,382,944-1.19-53.6%
1 Year2.433.540.85532.07944,474-1.40-57.61%
3 Years21.9033.280.85532.79540,888-20.87-95.3%
5 Years15.8033.280.85532.80480,564-14.77-93.48%

Aptorum Description

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. Its lead projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220516 06:23:12